caffeine has been researched along with Acquired Immunodeficiency Syndrome in 7 studies
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A spectrum of adverse drug reactions that are caused by the combined action of drugs and viruses has been described: ampicillin rash in acute infectious mononucleosis; Reye's syndrome; hypersensitivity reactions to sulphonamides in patients with HIV infection; drug-induced agranulocytosis; paracetamol (acetaminophen) hepatotoxicity; aspirin (acetylsalicyclic acid)-induced asthma; Epstein-Barr virus-associated lymphoma and methotrexate; and AIDS-related Kaposi's sarcoma and nitrite use." | 4.79 | Role of viral infections in the induction of adverse drug reactions. ( Levy, M, 1997) |
| "To investigate the relationship between high incidence of adverse dapsone reactions in acquired immunodeficiency syndrome (AIDS) patients and slow acetylate phenotype or low plasma/lymphocyte glutathione level of these patients." | 3.69 | Relationship between high incidence of adverse dapsone reactions and slow acetylate phenotype or low plasma/lymphocyte glutathione level. ( Guo, R; Lauterberg, B; Thormann, W, 1996) |
| "In a cross-sectional study, 105 HIV-positive patients and patients with acquired immunodeficiency syndrome (AIDS) were phenotyped for NAT2 activity with use of caffeine as an in vivo probe; 50 of these patients were also genotyped by restriction mapping and allele-specific amplification." | 3.69 | N-acetylation among HIV-positive patients and patients with AIDS: when is fast, fast and slow, slow? ( DiGirolamo, A; Gilfix, BM; O'Neil, WM; Tsoukas, CM; Wainer, IW, 1997) |
| "Caffeine was used to assess acetylation status and indexes of oxidative drug metabolism (demethylation, xanthine oxidation, and 8-hydroxylation) in a control group and in three groups of patients infected with human immunodeficiency virus (HIV): patients with acquired immunodeficiency syndrome (AIDS) who had acute illnesses, stable patients with AIDS, and asymptomatic patients infected with HIV." | 3.68 | Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. ( Benowitz, NL; Lee, BL; Sullam, PM; Wong, D, 1993) |
| "Isoniazid was administered at 300 mg once daily for 5 days to 80 adult volunteers." | 2.70 | Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid. ( Conte, JE; Duncan, S; Golden, JA; Kipps, J; McKenna, E; McQuitty, M; Zurlinden, E, 2002) |
| "One hundred and thirty-six AIDS patients were studied." | 1.31 | Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS. ( Aractingi, S; Beaune, P; Cabelguenne, A; Chosidow, O; Loriot, MA; Wolkenstein, P, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conte, JE | 1 |
| Golden, JA | 1 |
| McQuitty, M | 1 |
| Kipps, J | 1 |
| Duncan, S | 1 |
| McKenna, E | 1 |
| Zurlinden, E | 1 |
| Lee, BL | 1 |
| Wong, D | 1 |
| Benowitz, NL | 1 |
| Sullam, PM | 1 |
| Levy, M | 1 |
| Guo, R | 1 |
| Thormann, W | 1 |
| Lauterberg, B | 1 |
| O'Neil, WM | 1 |
| Gilfix, BM | 1 |
| DiGirolamo, A | 1 |
| Tsoukas, CM | 1 |
| Wainer, IW | 1 |
| Wolkenstein, P | 1 |
| Loriot, MA | 1 |
| Aractingi, S | 1 |
| Cabelguenne, A | 1 |
| Beaune, P | 1 |
| Chosidow, O | 1 |
| Weinberg, CR | 1 |
1 review available for caffeine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Role of viral infections in the induction of adverse drug reactions.
Topics: Acquired Immunodeficiency Syndrome; Agranulocytosis; Ampicillin; Caffeine; Drug-Related Side Effects | 1997 |
1 trial available for caffeine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid.
Topics: Acetylation; Acquired Immunodeficiency Syndrome; Adult; Antitubercular Agents; Body Fluids; Bronchoa | 2002 |
5 other studies available for caffeine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome.
Topics: Acetylation; Acquired Immunodeficiency Syndrome; Adult; Analysis of Variance; Caffeine; Coffee; Fema | 1993 |
Relationship between high incidence of adverse dapsone reactions and slow acetylate phenotype or low plasma/lymphocyte glutathione level.
Topics: Acetylation; Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Caffeine; Chromatogra | 1996 |
N-acetylation among HIV-positive patients and patients with AIDS: when is fast, fast and slow, slow?
Topics: Acetylation; Acquired Immunodeficiency Syndrome; Alleles; Arylamine N-Acetyltransferase; Caffeine; C | 1997 |
Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS.
Topics: Acetylation; Acquired Immunodeficiency Syndrome; Adult; Arylamine N-Acetyltransferase; Caffeine; Eva | 2000 |
Applicability of the simple independent action model to epidemiologic studies involving two factors and a dichotomous outcome.
Topics: Abortion, Spontaneous; Acquired Immunodeficiency Syndrome; Biometry; Caffeine; Epidemiologic Methods | 1986 |